Z

Zhejiang Jiuzhou Pharmaceutical Co Ltd
SSE:603456

Watchlist Manager
Zhejiang Jiuzhou Pharmaceutical Co Ltd
SSE:603456
Watchlist
Price: 13.86 CNY -0.07% Market Closed
Market Cap: 12.4B CNY

Zhejiang Jiuzhou Pharmaceutical Co Ltd's latest stock split occurred on Apr 12, 2018

The company executed a 195077-for-108376 stock split, meaning that for every 108376 shares held, investors received 195077 new shares.

Before the split, Zhejiang Jiuzhou Pharmaceutical Co Ltd traded at 17.79 per share. Afterward, the share price was about 9.2552.

The adjusted shares began trading on Apr 12, 2018. This was Zhejiang Jiuzhou Pharmaceutical Co Ltd's 2nd stock split, following the previous one in May 26, 2016.

Last Splits:
Apr 12, 2018
195077-for-108376
May 26, 2016
2-for-1
Pre-Split Price
9.2968 17.79
Post-Split Price
9.2552
Before
After
Last Splits:
Apr 12, 2018
195077-for-108376
May 26, 2016
2-for-1

Zhejiang Jiuzhou Pharmaceutical Co Ltd
Stock Splits History

Zhejiang Jiuzhou Pharmaceutical Co Ltd Stock Splits Timeline
Apr 12, 2018
Apr 12, 2018
Split 195077-for-108376
x1.800001845427
Pre-Split Price
9.2968 17.79
Post-Split Price
9.2552
Before
After
May 26, 2016
May 26, 2016
Split 2-for-1
x2
Pre-Split Price
13.7229 53.4601
Post-Split Price
14.0863
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Apr 22, 2025
Seres Therapeutics Inc
SWB:1S9
1-for-20
/20
0.3216 6.432 EUR 6.432 6.432 EUR
Apr 22, 2025
G
Golden Shield Resources Inc
F:4LE0
1-for-10
/10
0.011 0.11 EUR 0.11 0.11 EUR
Apr 22, 2025
E
EV Advanced Material Co Ltd
KOSDAQ:131400
911-for-787
x1.1575603557814
1493 1493 KRW 1439 1439 KRW
Apr 22, 2025
Seres Therapeutics Inc
F:1S9
1-for-20
/20
0.01 0.2 EUR 0.2 0.2 EUR
Apr 22, 2025
G
Golden Shield Resources Inc
OTC:GSRFF
1-for-10
/10
0.024 0.24 USD 0.24 0.24 USD
Load More

Zhejiang Jiuzhou Pharmaceutical Co Ltd
Glance View

Market Cap
12.3B CNY
Industry
Pharmaceuticals

Founded in 1973, Zhejiang Jiuzhou Pharmaceutical Co. Ltd. has steadily navigated the evolving tides of the global pharmaceutical industry with a compelling blend of innovation and traditional business acumen. Rooted in China's dynamic Zhejiang province, the company initially focused on manufacturing basic pharmaceutical intermediates. Over the years, it strategically expanded its operations, becoming a key player in both the Active Pharmaceutical Ingredients (APIs) and Contract Development and Manufacturing Organization (CDMO) sectors. This dual focus has allowed Jiuzhou Pharmaceutical to innovate and offer comprehensive services, ranging from drug development to commercial manufacturing, effectively appealing to a broad range of customers including some of the world's leading pharmaceutical companies. At the heart of Jiuzhou Pharmaceutical's success lies its commitment to research and development, a cornerstone that supports its diversification strategy. The company leverages its extensive expertise and cutting-edge technology to improve existing drugs while also participating in the development of new, patented pharmaceuticals. By fostering strong partnerships with global pharmaceutical giants, Jiuzhou effectively integrates itself into the larger pharmaceutical ecosystem, providing customized solutions that resonate with market demand. This business model not only reinforces its financial growth but also establishes Zhejiang Jiuzhou as an indispensable contributor to advancements in medicine, continually enhancing its reputation on the international stage.

Intrinsic Value
16.14 CNY
Undervaluation 14%
Intrinsic Value
Price
Z
Back to Top